HIV-associated Neuropathy

Polyneuropathy

SAB 15 mg per day for 5 days, the 15 mg BID (twice a day) for 5 days, then 15 mg TID (three times a day) to end of 28-day treatment period, in combination with active methadone 5 mg BID for 5 days, then 5 mg TID for 5 days, to maximum of 10 mg TID until end of 28-day treatment period

SAB378

Methadone 5 mg BID (twice a day) for 5 days, then 5 mg TID (three times a day) for 5 days, to maximum of 10 mg TID, in combination with SAB placebo or SAB active drug titrated as above, to end of 28-day treatment period.

methadone

SAB placebo

Methadone placebo

University of California, San Diego

University of New York Downstate Medical Center

University of Rochester

Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy

NARC 011: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Methadone and Combination of Methadone and SAB378 in HIV-associated Painful Peripheral Neuropathy

Washington University School of Medicine

National Institute of Neurological Disorders and Stroke (NINDS)

Neuropathic Pain

Smoked cannabis

UC San Diego, Hillcrest Medical Center

Medicinal Cannabis for Painful HIV Neuropathy

Placebo-Controlled, Double Blind Trial of Medicinal Cannabis in Painful HIV Neuropathy

polyneuropathies/konoplja

Combination of an Investigational Cannabinoid and Methadone for HIV-associated Neuropathy

Medicinal Cannabis for Painful HIV Neuropathy

Najkompletnija baza ljekovitog bilja potpomognuta znanošću